title: Japanese Guideline for Atopic Dermatitis 2014.
abstract: Given the importance of appropriate diagnosis and appropriate assessment of cutaneous symptoms in treatment of atopic dermatitis, the basics of treatment in this guideline are composed of (1) investigation and countermeasures of causes and exacerbating factors, (2) correction of skin dysfunctions (skin care), and (3) pharmacotherapy, as three mainstays. These are based on the disease concept that atopic dermatitis is a inflammatory cutaneous disease with eczema by atopic diathesis, multi-factorial in onset and aggravation, and accompanied by skin dysfunctions. These three points are equally important and should be appropriately combined in accordance with the symptoms of each patient. In treatment, it is important to transmit the etiological, pathological, physiological, or therapeutic information to the patient to build a favorable partnership with the patient or his/her family so that they may fully understand the treatment. This guideline discusses chiefly the basic therapy in relation to the treatment of this disease. The goal of treatment is to enable patients to lead an uninterrupted social life and to control their cutaneous symptoms so that their quality of life (QOL) may meet a satisfactory level. The basics of treatment discussed in this guideline are based on the "Guidelines for the Treatment of Atopic Dermatitis 2008" prepared by the Health and Labour Sciences Research and the "Guidelines for the Management of Atopic Dermatitis 2012 (ADGL2012)" prepared by the Atopic Dermatitis Guidelines Advisory Committee, Japanese Society of Allergology in principle. The guidelines for the treatment of atopic dermatitis are summarized in the "Japanese Guideline for the Diagnosis and Treatment of Allergic Disease 2013" together with those for other allergic diseases.
authors.affiliation: Department of Dermatology, Course of Integrated Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.
authors.forename: Ichiro
authors.initials: I
authors.lastname: Katayama
authors.affiliation: Chiba Rosai Hospital, Chiba, Japan.
authors.forename: Yoichi
authors.initials: Y
authors.lastname: Kohno
authors.affiliation: National Hospital Organization, Sagamihara National Hospital, Kanagawa, Japan.
authors.forename: Kazuo
authors.initials: K
authors.lastname: Akiyama
authors.affiliation: Department of Dermatology, Yokohama City University, Kanagawa, Japan.
authors.forename: Michiko
authors.initials: M
authors.lastname: Aihara
authors.affiliation: Department of Pediatrics, Graduate School of Medicine, Gifu University, Gifu, Japan.
authors.forename: Naomi
authors.initials: N
authors.lastname: Kondo
authors.affiliation: Department of Dermatology, Nippon Medical School, Tokyo, Japan.
authors.forename: Hidehisa
authors.initials: H
authors.lastname: Saeki
authors.affiliation: National Hospital Organization, Tokyo National Hospital, Tokyo, Japan.
authors.forename: Shunsuke
authors.initials: S
authors.lastname: Shoji
authors.affiliation: Department of Dermatology, Nara Hospital Kinki University Faculty of Medicine, Nara, Japan.
authors.forename: Hidekazu
authors.initials: H
authors.lastname: Yamada
authors.affiliation: Department of Dermatology, Saitama Medical University, Saitama, Japan.
authors.forename: Koichiro
authors.initials: K
authors.lastname: Nakamura
mesh_terms: D003876:Dermatitis, Atopic / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D007564:Japan; D010353:Patient Education as Topic; D011788:Quality of Life; D012867:Skin / Q000187:drug effects / Q000276:immunology* / Q000473:pathology; D017592:Skin Care / Q000379:methods